Over a quarter of EU adults would refuse Covid-19 shot, survey says

The results also suggested a strong link between vaccine hesitancy and the use of social media, particularly where social media is the main source of information

EU, Vaccine passports, Airports, travellers
Photo: Bloomberg
Reuters Brussels
2 min read Last Updated : May 13 2021 | 3:47 PM IST
More than a quarter of adults in the European Union would be unlikely to take the Covid-19 vaccine when it was offered to them, a survey published on Thursday showed.

The results also suggested a strong link between vaccine hesitancy and the use of social media, particularly where social media is the main source of information, according to Eurofound which carried out the survey.

"Unfortunately, these findings reflect a failure to deliver persuasive and clear communication regarding the efficacy and safety of vaccines," said Daphne Ahrendt, Eurofound senior research manager.

Bulgarians were the most reluctant to get the vaccine, with 67 per cent of adults saying they were unlikely or very unlikely to get it. In Ireland, only 10 per cent of adults said they would not get the shot.

The survey found an east-west divide across Europe. Except for France and Austria, the intention to get vaccinated was above 60 per cent in all Western member states - with Nordic and Mediterranean countries, Denmark and Ireland having even higher rates.

The rate of planned uptake in Eastern member states was much lower, ranging from 59 per cent in Romania to 33 per cent in Bulgaria.

The main influence on vaccine hesitancy was the time spent on social media and which medium was used, the survey said. The proportion rises to 40 per cent among those who use social media as their primary source of news.

Among people who used traditional media including press, radio and television, only 18 per cent of respondents were vaccine sceptics.

The survey also found that students, employed or retired people were less vaccine hesitant than average, while 39 per cent of unemployed people or those with a long-term disease of disability were more hesitant.

The survey was conducted between February and March 2021, after a full year of living with COVID-19 restrictions across the bloc's 27 member states.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineEuropean Union

Next Story